» Authors » L S Malatino

L S Malatino

Explore the profile of L S Malatino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 325
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G, et al.
J Intern Med . 2007 Dec; 263(3):274-80. PMID: 18070001
Background And Methods: Endogenous ouabain (EO) is markedly raised in patients with chronic renal failure. As high EO induces myocardial cell hypertrophy in vitro and it is associated with left...
2.
Malatino L, Stancanelli B, Cataliotti A, Bellanuova I, Fatuzzo P, Rapisarda F, et al.
J Intern Med . 2007 Sep; 262(4):479-87. PMID: 17875185
Background: E-selectin is a key adhesion molecule which plays a fundamental role in endothelial progenitor cell-dependent reparative mechanisms in experimental ischaemia and it serves to anchor leucocytes to the endothelium...
3.
Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino L, et al.
J Intern Med . 2003 Jul; 254(2):132-9. PMID: 12859694
Objective: Fibrinogen is an established predictor of cardiovascular events in the general population but the relationship between fibrinogen, mortality and incident cardiovascular complications has been very little investigated in patients...
4.
Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, et al.
Eur J Clin Invest . 2003 Jun; 33(7):561-6. PMID: 12814392
Background: We investigated the relationship between fibrinogen and echocardiographic measurements of left ventricular (LV) geometry and LV function in a group of 192 patients with end stage renal disease (ESRD)....
5.
Cataliotti A, Malatino L, Jougasaki M, Zoccali C, Castellino P, Giacone G, et al.
Mayo Clin Proc . 2001 Nov; 76(11):1111-9. PMID: 11702899
Objectives: To determine levels of natriuretic peptides (NPs) in patients with end-stage renal disease (ESRD) and to examine the relationship of these cardiovascular peptides to left ventricular hypertrophy (LVH) and...
6.
Enia G, Mallamaci F, Benedetto F, Panuccio V, Parlongo S, Cutrupi S, et al.
Nephrol Dial Transplant . 2001 Jun; 16(7):1459-64. PMID: 11427641
Background: Whether hypertension and left ventricular hypertrophy (LVH) are more prevalent in CAPD than in haemodialysis (HD) patients is still under discussion. Methods: To examine this problem we compared a...
7.
Mallamaci F, Zoccali C, Tripepi G, Benedetto F, Parlongo S, Cataliotti A, et al.
Kidney Int . 2001 Mar; 59(4):1559-66. PMID: 11260421
Background: In the general population, the plasma concentrations of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are useful to predict left ventricular hypertrophy (LVH) and LV systolic dysfunction....
8.
Malatino L, Mallamaci F, Benedetto F, Bellanuova I, Cataliotti A, Tripepi G, et al.
Am J Kidney Dis . 2000 Oct; 36(5):945-52. PMID: 11054350
Hepatocyte growth factor (HGF) is a pleiotropic cytokine involved in tissue protection and repair in the endothelium and various organ systems. The serum concentration of this protein is markedly increased...
9.
Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Fermo I, Foca A, et al.
J Hypertens . 2000 Sep; 18(9):1207-13. PMID: 10994751
Objective: To investigate the relationship between inflammatory processes and atherosclerosis in uraemic patients on chronic dialysis. Design: A cross-sectional study in 138 dialysis patients (92 on haemodialysis and 46 on...
10.
Malatino L, Bellanuova I, Cataliotti A, Cuzzola F, Mallamaci F, Tripepi G, et al.
J Nephrol . 2000 Aug; 13(3):178-84. PMID: 10928293
Methods: We investigated the influence of salt intake on urinary and plasma endothelin-1 (ET-1) in 55 patients who entered a two-week double-blind, randomised, crossover study comparing a 50 mMol/day salt...